{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:59:28Z","timestamp":1790258368684,"version":"4.1.0"},"reference-count":19,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_med-2026-1539_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Sepsis remains one of the most severe complications of infection. Specific and easily measurable biomarkers could help us predict the type of infection in sepsis. This study aimed to explore biomarkers for early identification of sepsis with different infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_med-2026-1539_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Serum was obtained from 37 patients with sepsis and 8 healthy individuals. Metabolites were screened using gas chromatography-mass spectrometry (GC-MS), and then potential biomarkers were screened. Receiver operating characteristic curve (ROC) analysis was used to evaluate potential biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_med-2026-1539_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 24 differential metabolites were found between sepsis subgroup with pulmonary infection and healthy controls, and they were enriched with 8 metabolic pathways. Similarly, 27 differential metabolites were identified in abdominal infection cases, and 64 in urinary tract infection (UTI) cases, which were associated with 23 and 26\u00a0metabolic pathways, respectively. Hydroxylamine and N-acetylputrescine may be used as candidate biomarkers to distinguish pulmonary infection and abdominal infection in sepsis, respectively, while glucose, phosphoenolpyruvate and\n                      <jats:sc>d<\/jats:sc>\n                      -ribose were good discriminators in\u00a0UTI.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_med-2026-1539_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our GC-MS-based metabolomic study identified potential biomarkers for sepsis across various infection types. These biomarkers show promise for the rapid and precise diagnosis of sepsis onset. Our GC-MS-based metabolomic study identified candidate metabolites associated with different infection sources in sepsis. Given the limited sample size and the correspondingly limited statistical power, these findings are exploratory and require prospective validation in an adequately powered, independent cohort before any diagnostic application can be considered.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/med-2026-1539","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:04:12Z","timestamp":1790255052000},"source":"Crossref","is-referenced-by-count":0,"title":["GC-MS metabolomics reveals potential biomarkers for infection-specific subtypes in sepsis"],"prefix":"10.1515","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1724-0444","authenticated-orcid":false,"given":"Cheng","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Emergency and Critical Care Medicine , Shanghai General Hospital Affiliated to Shanghai Jiao Tong University School of Medicine , Shanghai , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0577-1275","authenticated-orcid":false,"given":"Xinna","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology , Shanghai Tongji Hospital, Tongji University School of Medicine , Shanghai , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"2026092413040840127_j_med-2026-1539_ref_001","doi-asserted-by":"crossref","unstructured":"Cecconi, M, Evans, L, Levy, M, Rhodes, A. Sepsis and septic shock. Lancet 2018;392:75\u201387. https:\/\/doi.org\/10.1016\/S0140-6736(18)30696-2.","DOI":"10.1016\/S0140-6736(18)30696-2"},{"key":"2026092413040840127_j_med-2026-1539_ref_002","doi-asserted-by":"crossref","unstructured":"Llitjos, JF, Carrol, ED, Osuchowski, MF, Bonneville, M, Scicluna, BP, Payen, D, et al.. Enhancing sepsis biomarker development: key considerations from public and private perspectives. Crit Care 2024;28:238. https:\/\/doi.org\/10.1186\/s13054-024-05032-9.","DOI":"10.1186\/s13054-024-05032-9"},{"key":"2026092413040840127_j_med-2026-1539_ref_003","doi-asserted-by":"crossref","unstructured":"Chlorogiannis, DD, Epelboym, Y. Sepsis and common infections in interventional radiology. Tech Vasc Intervent Radiol 2025;28:101041. https:\/\/doi.org\/10.1016\/j.tvir.2025.101041.","DOI":"10.1016\/j.tvir.2025.101041"},{"key":"2026092413040840127_j_med-2026-1539_ref_004","doi-asserted-by":"crossref","unstructured":"Kaselitz, TB, Seymour, CW. Point-of-care ultrasound in sepsis and septic shock. JAMA 2025;333:1720\u20131. https:\/\/doi.org\/10.1001\/jama.2025.1983.","DOI":"10.1001\/jama.2025.1983"},{"key":"2026092413040840127_j_med-2026-1539_ref_005","doi-asserted-by":"crossref","unstructured":"Sinha, M, Jupe, J, Mack, H, Coleman, TP, Lawrence, SM, Fraley, SI. Emerging technologies for molecular diagnosis of sepsis. Clin Microbiol Rev 2018;31:e00089\u2013117. https:\/\/doi.org\/10.1128\/CMR.00089-17.","DOI":"10.1128\/CMR.00089-17"},{"key":"2026092413040840127_j_med-2026-1539_ref_006","doi-asserted-by":"crossref","unstructured":"Vijayan, AL, Vanimaya, Ravindran, S, Saikant, R, Lakshmi, S, Kartik, R, et al.. Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy. J\u00a0Intensiv Care 2017;5:51. https:\/\/doi.org\/10.1186\/s40560-017-0246-8.","DOI":"10.1186\/s40560-017-0246-8"},{"key":"2026092413040840127_j_med-2026-1539_ref_007","doi-asserted-by":"crossref","unstructured":"Gamazo Del R\u00edo, JJ, L\u00f3pez Izquierdo, R, Delgado C\u00e1rdenas, G, Saikant, R, Lakshmi, S, Kartik, R, et al.. Adult patients in the emergency department with sepsis or suspected serious infection: which patients should have blood cultures ordered? Emerge 2025;37:131\u201340. https:\/\/doi.org\/10.55633\/s3me\/007.2025.","DOI":"10.55633\/s3me\/007.2025"},{"key":"2026092413040840127_j_med-2026-1539_ref_008","doi-asserted-by":"crossref","unstructured":"Chen, C, Meng, X, Zhu, Y, Zhang, J, Wang, R. Early identification of serum biomarkers and pathways of sepsis through GC-MS-Based metabolomics analysis. Front Biosci (Landmark Ed) 2023;28:145. https:\/\/doi.org\/10.31083\/j.fbl2807145.","DOI":"10.31083\/j.fbl2807145"},{"key":"2026092413040840127_j_med-2026-1539_ref_009","doi-asserted-by":"crossref","unstructured":"Pierrakos, C, Velissaris, D, Bisdorff, M, Marshall, JC, Vincent, JL. Biomarkers of sepsis: time for a reappraisal. Crit Care 2020;24:287. https:\/\/doi.org\/10.1186\/s13054-020-02993-5.","DOI":"10.1186\/s13054-020-02993-5"},{"key":"2026092413040840127_j_med-2026-1539_ref_010","doi-asserted-by":"crossref","unstructured":"Oved, K, Cohen, A, Boico, O, Navon, R, Friedman, T, Etshtein, L, et al.. A novel host-proteome signature for distinguishing between acute bacterial and viral infections. PLoS One 2015;10:e0120012. https:\/\/doi.org\/10.1371\/journal.pone.0120012.","DOI":"10.1371\/journal.pone.0120012"},{"key":"2026092413040840127_j_med-2026-1539_ref_011","doi-asserted-by":"crossref","unstructured":"Payen, D, Lukaszewicz, A-C, Belikova, I, Faivre, V, Gelin, C, Russwurm, S, et al.. Gene profiling in human blood leucocytes during recovery from septic shock. Intensive Care Med 2008;34:1371\u20136. https:\/\/doi.org\/10.1007\/s00134-008-1048-1.","DOI":"10.1007\/s00134-008-1048-1"},{"key":"2026092413040840127_j_med-2026-1539_ref_012","doi-asserted-by":"crossref","unstructured":"Francois, B, Lambden, S, Fivez, T, Gibot, S, Derive, M, Grouin, JM, et al.. Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial. Lancet Respir Med 2023;11:894\u2013904. https:\/\/doi.org\/10.1016\/S2213-2600(23)00158-3.","DOI":"10.1016\/S2213-2600(23)00158-3"},{"key":"2026092413040840127_j_med-2026-1539_ref_013","doi-asserted-by":"crossref","unstructured":"Laterre, PF, Pickkers, P, Marx, G, Wittebole, X, Meziani, F, Dugernier, T, et al.. Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial. Intensive Care Med 2021;47:1284\u201394. https:\/\/doi.org\/10.1007\/s00134-021-06537-5.","DOI":"10.1007\/s00134-021-06537-5"},{"key":"2026092413040840127_j_med-2026-1539_ref_014","doi-asserted-by":"crossref","unstructured":"Conway Morris, A, Datta, D, Shankar-Hari, M, Stephen, J, Weir, CJ, Rennie, J, et al.. Cell-surface signatures of immune dysfunction risk-stratify critically ill patients: INFECT study. Intensive Care Med 2018;44:627\u201335. https:\/\/doi.org\/10.1007\/s00134-018-5247-0.","DOI":"10.1007\/s00134-018-5247-0"},{"key":"2026092413040840127_j_med-2026-1539_ref_015","doi-asserted-by":"crossref","unstructured":"Van Wyngene, L, Vandewalle, J, Libert, C. Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last? EMBO Mol Med 2018;10:e8712. https:\/\/doi.org\/10.15252\/emmm.201708712.","DOI":"10.15252\/emmm.201708712"},{"key":"2026092413040840127_j_med-2026-1539_ref_016","doi-asserted-by":"crossref","unstructured":"Ma, J, Wei, K, Liu, J, Tang, K, Zhang, H, Zhu, L, et al.. Glycogen metabolism regulates macrophage-mediated acute inflammatory responses. Nat Commun 2020;11:1769. https:\/\/doi.org\/10.1038\/s41467-020-15636-8.","DOI":"10.1038\/s41467-020-15636-8"},{"key":"2026092413040840127_j_med-2026-1539_ref_017","doi-asserted-by":"crossref","unstructured":"Chen, L, Zhang, Z, Hoshino, A, Zheng, HD, Morley, M, Arany, Z, et al.. NADPH production by the oxidative pentose-phosphate pathway supports folate metabolism. Nat Metab 2019;1:404\u201315. https:\/\/doi.org\/10.1038\/s42255-019-0043-x.","DOI":"10.1038\/s42255-019-0043-x"},{"key":"2026092413040840127_j_med-2026-1539_ref_018","doi-asserted-by":"crossref","unstructured":"Jorge, JM, Leggewie, C, Wendisch, VF. A new metabolic route for the production of gamma-aminobutyric acid by Corynebacterium glutamicum from glucose. Amino Acids 2016;48:2519\u201331. https:\/\/doi.org\/10.1007\/s00726-016-2272-6.","DOI":"10.1007\/s00726-016-2272-6"},{"key":"2026092413040840127_j_med-2026-1539_ref_019","doi-asserted-by":"crossref","unstructured":"Wu, Q, Fang, JL, Nagumalli, SK, Guo, X, Beland, FA. NAD(P)(+)- dependent alcohol oxidoreductases oxidize 7-hydroxycannabidiol to a reactive formyl metabolite. Arch Toxicol 2025;99:4411\u201321. https:\/\/doi.org\/10.1007\/s00204-025-04140-x.","DOI":"10.1007\/s00204-025-04140-x"}],"container-title":["Open Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2026-1539\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2026-1539\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:04:18Z","timestamp":1790255058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2026-1539\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,9,24]]},"published-print":{"date-parts":[[2026,1,23]]}},"alternative-id":["10.1515\/med-2026-1539"],"URL":"https:\/\/doi.org\/10.1515\/med-2026-1539","relation":{},"ISSN":["2391-5463"],"issn-type":[{"value":"2391-5463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"20261539"}}